varsha chungde
☆    

India,
2018-10-08 13:34
(1988 d 18:23 ago)

Posting: # 19415
Views: 3,575
 

 Enoxaparin sodium injection BA BE studies [Regulatives / Guidelines]

Hi all,

As per guideline we need not to perform any Bioequivalence studies for Injectables. But Enoxaparin sodium being a biologically derived product, is there any need of performing the BA-BE studies.

Does the guideline differs for a biologically derived product?:confused::confused:confused:
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2018-10-08 13:53
(1988 d 18:04 ago)

@ varsha chungde
Posting: # 19416
Views: 3,274
 

 BE of parenterals

Hi Varsha,

❝ As per guideline we need not to perform any Bioequivalence studies for Injectables.


It’s not that simple. See e.g., the EMA’s GL page 23.

❝ But Enoxaparin sodium being a biologically derived product, is there any need of performing the BA-BE studies.


That’s not the point. See the FDA’s guidance for conditions whether the in vivo PD (!) study can be waived.

❝ Does the guideline differs for a biologically derived product?


Differ to what? To get an idea, see the EMA’s guidelines on biosimilars.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
nobody
nothing

2018-10-09 12:42
(1987 d 19:15 ago)

@ varsha chungde
Posting: # 19418
Views: 3,132
 

 Enoxaparin sodium injection BA BE studies

❝ As per guideline we need not to perform any Bioequivalence studies for Injectables.


That's simply not true at all.

There is a (draft) US guidance on BE for enoxaparine. Good starting point. Have fun!

Kindest regards, nobody
varsha chungde
☆    

India,
2018-10-10 09:09
(1986 d 22:48 ago)

@ nobody
Posting: # 19423
Views: 3,066
 

 Enoxaparin sodium injection BA BE studies

❝ There is a (draft) US guidance on BE for enoxaparine. Good starting point. Have fun!


The draft guidance says that we need to prove the sameness between API.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]
ElMaestro
★★★

Denmark,
2018-10-09 13:13
(1987 d 18:45 ago)

@ varsha chungde
Posting: # 19419
Views: 3,139
 

 Enoxaparin sodium injection BA BE studies

Hello varsha,

❝ As per guideline we need not to perform any Bioequivalence studies for Injectables.


You mean solutions. :-D

Pass or fail!
ElMaestro
varsha chungde
☆    

India,
2018-10-10 09:11
(1986 d 22:46 ago)

@ ElMaestro
Posting: # 19424
Views: 3,080
 

 Enoxaparin sodium injection BA BE studies

❝ You mean solutions. :-D


Yes i mean injectable aqueous solution. As enoxaparin injection is API in aqueous solution. But enoxaparin being a biotech product, i just needed an clarification. Do we need to prove our AP to be similar or good enough to waive the BE studies.


Edit 2018-10-10 07:14: The draft guidance also says to prove the sameness of API. [Varsha]


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! Merged with a later (deleted) post. You can edit your post within 24 hours. [Helmut]
UA Flag
Activity
 Admin contact
22,940 posts in 4,812 threads, 1,640 registered users;
40 visitors (0 registered, 40 guests [including 9 identified bots]).
Forum time: 06:58 CET (Europe/Vienna)

Those people who think they know everything
are a great annoyance to those of us who do.    Isaac Asimov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5